0       0


Clostridium Difficile: An Organism with a New Virulence


Jan 24, 2012 1:00pm ‐ Jan 24, 2012 2:30pm


Credits: None available.

Standard: $39.00
Members: $19.00

Description

  1. Summarize the etiology and pathogenesis of C. Difficile infections
  2. Distinguish among selective pharmaceutical agents that predispose patients to C. Difficile colitis
  3. Define the unique risk factors for patients with inflammatory bowel disease and C. Difficile infections and their treatment challenges

Speaker(s):

  • Deborah A. Andris, MSN, APNP, Nurse Practitioner, Division of Colorectal Surgery, Medical College of Wisconsin, Milwaukee, WI
  • Todd Canada, PharmD, BCNSP, BCCCP, FASHP, FTSHP, Nutrition Support Team Coordinator, University of Texas MD Anderson Cancer Center, Division of Pharmacy, Houston, TX

Speaker(s):

Credits

Credits: None available.

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content